Is a single infant priming dose of meningococcal serogroup C conjugate vaccine in the United Kingdom sufficient?

Figures & data

Figure 1. Proportion of subjects with SBA titres ≥8 by primary MCC vaccine (2 doses) and time since MenC/Hib-TT booster (Data from ref. 10).

Figure 2. MenC SBA GMTs (95% CI) by primary MCC vaccine (single dose) and following MenC/Hib-TT booster (Data from ref. 14).

Figure 3. Proportion of subjects with SBA titre ≥8 by primary MCC vaccine (single dose) and following MenC/Hib-TT booster (Data from ref. 14).

Figure 4. SBA GMTs 1 month following second dose of MCC at 14–18 months of age following MCC priming (Data from ref. 17).

Figure 5. SBA GMTs 1 month post 2 doses of MCC at 3 and 4 months of age (Data from ref. 20).

Borrow R, Andrews N, Findlow H, Waight P, Southern J, Crowley-Luke A, Stapley L, England A, Findlow J, Miller E. Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine. Clin Vaccin Immunol 2010; 17:154-159; PMID:19906895; http://dx.doi.org/10.1128/CVI.00384-09

 PubMed Web of Science ®Google Scholar

Findlow H, Borrow R, Andrews N, Waight P, Sheasby E, Matheson M, England A, Goldblatt D, Ashton L, Findlow J, et al. Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United Kingdom. Pediatr Infect Dis J 2012; 31:616-622; PMID:22333698; http://dx.doi.org/10.1097/INF.0b013e31824f34e6

 PubMed Web of Science ®Google Scholar

Díez-Domingo J1, Cantarino MV, Torrentí JM, Sansano MI, Rosich AJ, Merino AH, de Miguel AG, González JB, Marcos MD; MenC Study Group. A randomized, multicenter, open-label clinical trial to assess the immunogenicity of a meningococcal C vaccine booster dose administered to children aged 14 to 18 months. Pediatr Infect Dis J 2010; 29:148-152; PMID:19927040; http://dx.doi.org/10.1097/INF.0b013e3181b9a831

 PubMed Web of Science ®Google Scholar

Ladhani S, Andrews N, Waight P, Hallis B, Matheson M, England A, Findlow H, Bai X, Borrow R, Goldblatt D, et al. Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule. Vaccine 2015; 33:648-55.

 Google Scholar